Mitral regurgitation is a cardiovascular condition characterized by the backward flow of blood from the left ventricle into the left atrium of the heart. This occurs when the mitral valve, responsible for regulating blood flow between these chambers, does not close properly during each heartbeat. The inefficient closure leads to a leakage of blood, causing the heart to work harder to pump a sufficient amount of blood to meet the body's needs. Mitral regurgitation can result from various causes, such as mitral valve prolapse, rheumatic heart disease, or congenital abnormalities. Common symptoms include fatigue, shortness of breath, and a distinct heart murmur. Timely diagnosis and intervention are crucial to prevent complications and manage the condition effectively, often involving medications or, in severe cases, surgical repair or replacement of the mitral valve. Management strategies aim to alleviate symptoms, improve heart function, and enhance overall quality of life for individuals affected by mitral regurgitation. Regular monitoring and collaboration with healthcare professionals are key aspects of managing this cardiovascular condition.
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Study of pathological cardiac hypertrophy regression
Shuping Zhong, University of Southern California, United States
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Atypical takotsubo cardiomyopathy presenting as st-elevation myocardial infarction
Sana Tariq, Manchester University NHS Foundation Trust, United Kingdom